Published in:
04-04-2023 | Neuropathic Pain | Original Article
Stem cell therapy combined with luteolin alleviates experimental neuropathy
Authors:
Sajad Sahab Negah, Mehrdad Hajinejad, Saeideh Nemati, Seyyed Mohamad Javad Mahdipour Roudbary, Fatemeh Forouzanfar
Published in:
Metabolic Brain Disease
|
Issue 6/2023
Login to get access
Abstract
Neuropathic pain is a chronic condition that causes long-term burning sensations. Despite significant efforts, current treatments for neuropathic pain are ineffective in curing the condition, which means new therapeutic options must be developed. One such option is the use of stem cell therapy in combination with anti-inflammatory herbal components, which has shown promise in treating neuropathic pain. The study aimed to investigate the effects of bone marrow mesenchymal stem cells (BM-MSCs) with luteolin on sensory deficits and pathological changes in a neuropathic model. The results showed that luteolin, either alone or in combination with BM-MSCs, effectively reduced sensory deficits related to mechanical and thermal hypersensitivity. In addition, luteolin alone and combined with BM-MSCs reduced oxidative stress in neuropathic rats and inhibited cellular responses, particularly reactive astrocytes. The study concluded that combining luteolin and BM-MSCs may offer an effective therapeutic strategy for patients with neuropathic pain, although further research is needed.